| 4:30 p.m. |
|
Other Tri-Institutional Events
Translational Research at MSKCC
David Solit, M.D., department of medicine and human oncology and pathogenesis program, Memorial Sloan-Kettering Cancer Center Paul Chapman, M.D., department of medicine, Memorial Sloan-Kettering Cancer Center, Mechanisms of Tumor Response and Resistance in Melanoma Patients with V600E-mutated BRAF Treated with Vemurafenib Jedd Wolchok, M.D., Ph.D., department of medicine, Memorial Sloan-Kettering Cancer Center, Immunotherapy for Melanoma: The End of the Beginning James Allison, Ph.D., immunology program and department of medicine, Memorial Sloan-Kettering Cancer Center
|
